Home > Press > Nanostart AG appoints HSBC Trinkaus as new Designated Sponsor
Abstract:
Nanostart AG has, with effect from October 1, 2010, appointed HSBC Trinkaus & Burkhardt, part of the HSBC Group, as a new Designated Sponsor.
With some 300,000 employees and 8,000 office locations across 87 countries, HSBC Group is one of the world's largest banking and financial services organizations. Within Germany, its subsidiary HSBC Trinkaus & Burkhardt is one of the country's leading and longest established private banks. Its staff of 2,295 serves private, corporate and institutional clients from seven office locations throughout Germany. With a "AA" rating from Fitch (confirmed in December 2009), the bank is the highest rated private commercial bank in Germany.
As Designated Sponsor, HSBC Trinkaus will provide liquidity to the ongoing trading of the company's shares on the XETRA system through binding bid and offer quotes. In addition, HSBC will assist the company in its efforts to reach out to investors, in Germany and around the world.
"The expertise and worldwide network which HSBC Trinkaus offers as part of a major global banking group makes it, as Designated Sponsor, an ideal partner for a globally expanding company such as Nanostart," explained Marco Beckmann, CEO of Nanostart AG.
Mark Kahlenberg, head of corporate broking at HSBC Trinkaus, added: "We look forward to working with Nanostart AG as an international investment company in one of the strongest growing sectors."
Close Brothers Seydler AG will continue to serve as a Designated Sponsor for Nanostart shares alongside HSBC Trinkaus.
####
About Nanostart AG
Nanostart AG, headquartered in the German financial capital of Frankfurt, is the world’s leading nanotechnology investment company, with portfolio companies spanning the globe from Silicon Valley to Singapore. The company provides venture capital financing for nanotechnology companies in various growth phases with a focus on innovation-driven industries of the future such as cleantech, life sciences and IT/electronics. Through its subsidiary and venture capital fund in Singapore, Nanostart is proud to be the investment partner of the Singaporean government.
Disclaimer:
This notice constitutes neither an offer to sell nor a solicitation of offers to purchase or subscribe to securities. There will be no public offering of securities of Nanostart AG in conjunction with the existing listing of its shares in the “Entry Standard” segment of the regulated unofficial market (Freiverkehr) on the Frankfurt Stock Exchange. This notice does not constitute a securities prospectus. Neither this notice nor the information contained within is intended for direct or indirect distribution within the United States of America, Canada, Australia or Japan.
For more information, please click here
Contacts:
Nanostart AG
Public Relations
Dr. Hans Joachim Dürr
Goethestrasse 26-28
D-60313 Frankfurt
Germany
phone: +49 (0)69-21 93 96 111
fax: +49 (0)69-21 93 96 122
e-mail:
Copyright © Nanostart AG
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||